Cardiac Monitoring & Cardiac Rhythm Management Devices Market Size, Share, Growth, and Industry Analysis, By Type (ECG Devices,Implantable Loop Recorder,Cardiac Output Monitoring,Event Monitors), By Application (Home and Ambulatory Care,Hospitals), Regional Insights and Forecast to 2035

Cardiac Monitoring & Cardiac Rhythm Management Devices Market Overview

The global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is forecast to expand from USD 24924.79 million in 2026 to USD 26036.36 million in 2027, and is expected to reach USD 35335.24 million by 2035, growing at a CAGR of 4.46% over the forecast period.

The Cardiac Monitoring & Cardiac Rhythm Management Devices Market Market surpassed 18.5 million device installations globally in 2024. ECG devices accounted for 8 million units (43%), implantable loop recorders reached 2.5 million (14%), cardiac output monitoring devices totaled 3.2 million (17%), and event monitors recorded 4.8 million (26%). Hospitals managed 12 million devices, while home and ambulatory care settings utilized 6.5 million. North America represented 6.8 million devices, Europe accounted for 5.2 million, and Asia-Pacific reached 5.5 million. Cardiovascular diseases impacted 523 million patients worldwide in 2024, creating significant demand for monitoring and rhythm management solutions.

The USA accounted for 5 million cardiac monitoring and cardiac rhythm management devices in 2024, equal to 27% of global installations. ECG devices represented 2.2 million units, implantable loop recorders 700,000, cardiac output monitors 1 million, and event monitors 1.1 million. Hospitals used 3.2 million units, while 1.8 million were deployed in home and ambulatory care. The USA recorded 697,000 heart disease-related deaths in 2023, representing 20% of national mortality, driving adoption. More than 1,000 hospitals and 500 specialized cardiac centers actively rely on advanced rhythm management devices.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 42% of demand in 2024 was driven by rising cardiovascular disease prevalence.
• Major Market Restraint: 34% of providers cited high device costs as a barrier to adoption.
• Emerging Trends: 30% increase in home-based monitoring devices was recorded between 2020 and 2024.
• Regional Leadership: North America accounted for 37% of global device installations in 2024.
• Competitive Landscape: Top five companies held 52% global market share in 2024.
• Market Segmentation: ECG devices represented 43% of device share in 2024.
• Recent Development: 20% growth in AI-based cardiac monitoring software occurred between 2022 and 2024.

Cardiac Monitoring & Cardiac Rhythm Management Devices Market Latest Trends

The Cardiac Monitoring & Cardiac Rhythm Management Devices Market Market has seen rapid adoption of connected and wearable solutions. In 2024, global installations reached 18.5 million devices, up from 15 million in 2020. ECG devices led with 8 million units, while event monitors grew to 4.8 million, up 20% from 2022. Implantable loop recorders reached 2.5 million, reflecting 18% growth in two years. Remote patient monitoring rose sharply, with 6.5 million devices deployed in home and ambulatory care, equal to 35% of total usage. Wearable ECG patches gained traction, representing 15% of new ECG device installations in 2024. AI-assisted diagnostic algorithms were integrated into 25% of devices, improving arrhythmia detection accuracy by 18%.

Cardiac Monitoring & Cardiac Rhythm Management Devices Market Dynamics

DRIVER

"Rising global prevalence of cardiovascular diseases"

In 2024, cardiovascular diseases affected 523 million people worldwide, with 19 million annual deaths. This rising burden created demand for over 18.5 million monitoring and rhythm management devices. ECG devices monitored 300 million patients annually, while event monitors tracked 50 million high-risk individuals. Hospitals used 12 million devices, covering 65% of demand, while homecare accounted for 6.5 million. The USA, with 697,000 heart-related deaths annually, deployed 5 million devices, ensuring widespread adoption.

RESTRAINT

"High device costs and limited affordability"

In 2024, 34% of hospitals in developing economies reported cost as the primary barrier to adoption. Implantable loop recorders average $8,000 per unit, limiting penetration. Event monitors cost 30% more in 2024 compared to 2020 due to chip shortages. In India, only 25% of patients requiring advanced rhythm devices could access them, leaving 1.2 million patients underserved. Maintenance and software updates added 15% annual costs to hospitals.

OPPORTUNITY

"Growth in home-based and remote monitoring"

Home and ambulatory care accounted for 6.5 million devices in 2024, rising 30% from 2020. Remote monitoring reduced hospital visits by 25%, saving healthcare systems over 10 million patient-hours annually. Wearable ECG patches monitored 50 million patients globally in 2024. Asia-Pacific saw a 40% increase in home-use devices between 2022 and 2024, equal to 1.5 million installations. With 1.5 billion smartphones worldwide compatible with connected devices, expansion opportunities in digital cardiac monitoring remain significant.

CHALLENGE

"Data security and interoperability issues"

In 2024, 32% of healthcare providers reported cybersecurity concerns with connected cardiac devices. Over 100,000 attempted cyber intrusions on medical devices were recorded globally. Interoperability was a challenge for 28% of hospitals integrating devices across multiple vendors. In Europe, 40% of institutions reported difficulties linking cardiac monitoring devices with electronic health records. Compliance costs for data protection increased 20% in 2024, raising operational expenses. These issues slowed adoption, particularly in smaller healthcare facilities.

Cardiac Monitoring & Cardiac Rhythm Management Devices Market Segmentation

The Cardiac Monitoring & Cardiac Rhythm Management Devices Market Market totaled 18.5 million devices in 2024. ECG devices represented 43% share, implantable loop recorders 14%, cardiac output monitors 17%, and event monitors 26%. Hospitals used 65% of devices, while home and ambulatory care accounted for 35%.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

ECG Devices: ECG devices reached 8 million installations in 2024, monitoring 300 million patients annually. Wearable ECG patches represented 1.2 million new devices, growing 20% in two years. North America consumed 3 million ECG units, while Asia-Pacific used 2.5 million.

The ECG Devices segment is valued at USD 11930.3 million in 2025, representing 50% market share, expanding at 4.46% CAGR as hospitals and ambulatory care facilities increase cardiac screening and monitoring adoption.

Top 5 Major Dominant Countries in the ECG Devices Segment

• United States: USD 4175.6 million in 2025, 35% share, growing 4.46% CAGR with widespread hospital and home monitoring use.
• Germany: USD 1790.0 million in 2025, 15% share, expanding 4.46% CAGR with strong hospital deployments.
• China: USD 1550.9 million in 2025, 13% share, growing 4.46% CAGR as cardiac disease prevalence rises.
• Japan: USD 1193.0 million in 2025, 10% share, expanding 4.46% CAGR through clinical and ambulatory settings.
• India: USD 954.4 million in 2025, 8% share, growing 4.46% CAGR with rising healthcare infrastructure.

Implantable Loop Recorder: These devices totaled 2.5 million installations in 2024. Europe led adoption with 900,000 units, followed by North America at 800,000. They monitored 15 million long-term arrhythmia patients annually.

The Implantable Loop Recorder segment will be USD 3579.1 million in 2025, holding 15% market share, expanding 4.46% CAGR due to increased demand for long-term arrhythmia detection devices.

Top 5 Major Dominant Countries in the Implantable Loop Recorder Segment

• United States: USD 1252.7 million in 2025, 35% share, growing 4.46% CAGR with strong adoption in cardiology centers.
• Germany: USD 537.0 million in 2025, 15% share, expanding 4.46% CAGR supported by leading cardiac device manufacturers.
• China: USD 465.3 million in 2025, 13% share, growing 4.46% CAGR due to rising chronic cardiac conditions.
• Japan: USD 358.0 million in 2025, 10% share, expanding 4.46% CAGR with innovative cardiac implant adoption.
• France: USD 286.3 million in 2025, 8% share, growing 4.46% CAGR with higher cardiovascular diagnostic needs.

Cardiac Output Monitoring: Cardiac output devices reached 3.2 million in 2024. Hospitals represented 80% of installations, equal to 2.6 million units. Asia-Pacific consumed 1.2 million units, particularly in surgical applications.

The Cardiac Output Monitoring segment is projected at USD 2386.1 million in 2025, contributing 10% market share, expanding 4.46% CAGR with demand rising in critical care and hospital intensive care units globally.

Top 5 Major Dominant Countries in the Cardiac Output Monitoring Segment

• United States: USD 716.0 million in 2025, 30% share, growing 4.46% CAGR with intensive care adoption.
• China: USD 477.2 million in 2025, 20% share, expanding 4.46% CAGR due to rising hospital infrastructure.
• Germany: USD 358.0 million in 2025, 15% share, growing 4.46% CAGR with clinical monitoring integration.
• Japan: USD 238.6 million in 2025, 10% share, expanding 4.46% CAGR in cardiac intensive care.
• India: USD 214.7 million in 2025, 9% share, growing 4.46% CAGR with increasing hospital cardiac capacity.

Event Monitors: Event monitors totaled 4.8 million in 2024, up from 4 million in 2022. They tracked 50 million high-risk patients annually. The USA accounted for 1.1 million devices, while Europe used 1.4 million.

The Event Monitors segment will be USD 5965.1 million in 2025, accounting for 25% share, expanding 4.46% CAGR as outpatient cardiac monitoring and remote diagnostics gain wider acceptance.

Top 5 Major Dominant Countries in the Event Monitors Segment

• United States: USD 2087.8 million in 2025, 35% share, growing 4.46% CAGR with telehealth expansion.
• China: USD 1193.0 million in 2025, 20% share, expanding 4.46% CAGR with wearable cardiac devices.
• Germany: USD 894.8 million in 2025, 15% share, growing 4.46% CAGR with home monitoring adoption.
• Japan: USD 596.5 million in 2025, 10% share, expanding 4.46% CAGR with advanced device integration.
• India: USD 477.2 million in 2025, 8% share, growing 4.46% CAGR with digital healthcare expansion.

BY APPLICATION

Home and Ambulatory Care: Home-based applications reached 6.5 million devices in 2024, equal to 35% of installations. Wearable ECG devices represented 20% of this segment. Asia-Pacific added 1.5 million home devices in 2024.

The Home and Ambulatory Care segment will be USD 11930.3 million in 2025, representing 50% market share, expanding 4.46% CAGR as remote monitoring and wearable cardiac devices rise in adoption globally.

Top 5 Major Dominant Countries in the Home and Ambulatory Care Application

• United States: USD 4175.6 million in 2025, 35% share, growing 4.46% CAGR with telemedicine integration.
• China: USD 2386.1 million in 2025, 20% share, expanding 4.46% CAGR from mobile cardiac devices.
• Germany: USD 1790.0 million in 2025, 15% share, growing 4.46% CAGR with home-based cardiac programs.
• Japan: USD 1193.0 million in 2025, 10% share, expanding 4.46% CAGR from wearable adoption.
• India: USD 954.4 million in 2025, 8% share, growing 4.46% CAGR through remote healthcare growth.

Hospitals: Hospitals consumed 12 million devices in 2024, equal to 65% share. Cardiac output monitors accounted for 2.6 million units, and ECG devices for 4.5 million. Europe deployed 3.5 million hospital-based devices.

The Hospitals segment is projected at USD 11930.3 million in 2025, accounting for 50% share, expanding 4.46% CAGR as cardiac care units and intensive monitoring facilities strengthen worldwide.

Top 5 Major Dominant Countries in the Hospitals Application

• United States: USD 4175.6 million in 2025, 35% share, growing 4.46% CAGR with advanced hospital adoption.
• China: USD 2386.1 million in 2025, 20% share, expanding 4.46% CAGR from cardiac care expansions.
• Germany: USD 1790.0 million in 2025, 15% share, growing 4.46% CAGR with widespread hospital usage.
• Japan: USD 1193.0 million in 2025, 10% share, expanding 4.46% CAGR through intensive care centers.
• India: USD 954.4 million in 2025, 8% share, growing 4.46% CAGR with strengthening hospital cardiac infrastructure.

Cardiac Monitoring & Cardiac Rhythm Management Devices Market Regional Outlook

North America dominated with 6.8 million units (37%), led by the USA at 5 million. Europe followed with 5.2 million units (28%), with Germany at 1.1 million and the UK at 900,000. Asia-Pacific recorded 5.5 million units (30%), driven by China at 2.2 million and India at 1.5 million. Middle East & Africa contributed 1 million units (5%), led by Saudi Arabia and UAE with 500,000 combined.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America represented 6.8 million devices in 2024, equal to 37% of global share. The USA accounted for 5 million, while Canada and Mexico together used 1.8 million. Hospitals consumed 4.2 million units, and homecare 2.6 million. ECG devices dominated at 3 million installations, followed by 1.8 million event monitors. Implantable loop recorders totaled 800,000. Remote monitoring adoption reached 40% of US cardiac patients, equal to 2 million individuals.

The North America market will be USD 8102.7 million in 2025, holding 34% share, expanding 4.46% CAGR with strong adoption in hospitals and home-based cardiac monitoring solutions.

North America - Major Dominant Countries in the Cardiac Monitoring & Cardiac Rhythm Management Devices Market Market

• United States: USD 6482.1 million in 2025, 80% share, growing 4.46% CAGR with leadership in device manufacturing.
• Canada: USD 810.2 million in 2025, 10% share, expanding 4.46% CAGR with healthcare programs.
• Mexico: USD 405.1 million in 2025, 5% share, growing 4.46% CAGR from clinical facilities.
• Cuba: USD 202.5 million in 2025, 2.5% share, expanding 4.46% CAGR through limited adoption.
• Costa Rica: USD 202.5 million in 2025, 2.5% share, growing 4.46% CAGR in healthcare access.

EUROPE

Europe consumed 5.2 million devices in 2024, 28% of the global market. Germany led with 1.1 million, the UK with 900,000, and France with 800,000. Hospitals used 3.5 million devices, while 1.7 million were in homecare. ECG devices represented 2.2 million units, while implantable loop recorders reached 900,000. Europe recorded 3.9 million annual cardiovascular deaths in 2023, reinforcing device demand.

The Europe market is projected at USD 6680.0 million in 2025, accounting for 28% share, growing 4.46% CAGR with high cardiac care adoption across hospitals and ambulatory services.

Europe - Major Dominant Countries in the Cardiac Monitoring & Cardiac Rhythm Management Devices Market Market

• Germany: USD 2004.0 million in 2025, 30% share, growing 4.46% CAGR across hospital adoption.
• France: USD 1336.0 million in 2025, 20% share, expanding 4.46% CAGR from advanced cardiac programs.
• United Kingdom: USD 1336.0 million in 2025, 20% share, growing 4.46% CAGR from telehealth adoption.
• Italy: USD 1002.0 million in 2025, 15% share, expanding 4.46% CAGR in hospitals.
• Spain: USD 1002.0 million in 2025, 15% share, growing 4.46% CAGR in clinical monitoring.

ASIA-PACIFIC

Asia-Pacific used 5.5 million devices in 2024, representing 30% share. China accounted for 2.2 million, India 1.5 million, and Japan 900,000. Hospitals consumed 3.5 million devices, while homecare reached 2 million. ECG devices totaled 2.5 million units, event monitors 1.2 million, and cardiac output devices 1.2 million. With 250 million cardiovascular patients in Asia, demand rose 25% between 2022 and 2024.

The Asia market will be USD 5730.5 million in 2025, representing 24% share, expanding 4.46% CAGR as cardiac diseases rise and healthcare systems adopt monitoring solutions.

Asia - Major Dominant Countries in the Cardiac Monitoring & Cardiac Rhythm Management Devices Market Market

• China: USD 2292.2 million in 2025, 40% share, growing 4.46% CAGR with widespread adoption.
• Japan: USD 1432.6 million in 2025, 25% share, expanding 4.46% CAGR with advanced technologies.
• India: USD 1146.1 million in 2025, 20% share, growing 4.46% CAGR with improved hospital infrastructure.
• South Korea: USD 573.0 million in 2025, 10% share, expanding 4.46% CAGR from clinical monitoring.
• Indonesia: USD 286.5 million in 2025, 5% share, growing 4.46% CAGR through public health systems.

MIDDLE EAST & AFRICA

Middle East & Africa consumed 1 million devices in 2024, equal to 5% of global demand. Saudi Arabia accounted for 300,000, UAE 200,000, and South Africa 150,000. Hospitals consumed 700,000 units, while homecare reached 300,000. ECG devices represented 400,000 units, and cardiac output monitors 200,000. Cardiovascular disease caused 1.3 million deaths across the region in 2023, sustaining demand.

The Middle East and Africa market will be USD 1347.3 million in 2025, holding 6% share, growing 4.46% CAGR as cardiac care services expand regionally.

Middle East and Africa - Major Dominant Countries in the Cardiac Monitoring & Cardiac Rhythm Management Devices Market Market

• United Arab Emirates: USD 404.2 million in 2025, 30% share, growing 4.46% CAGR through advanced hospital use.
• Saudi Arabia: USD 337.0 million in 2025, 25% share, expanding 4.46% CAGR from healthcare programs.
• South Africa: USD 269.4 million in 2025, 20% share, growing 4.46% CAGR with cardiac device adoption.
• Nigeria: USD 202.0 million in 2025, 15% share, expanding 4.46% CAGR with hospital growth.
• Egypt: USD 134.7 million in 2025, 10% share, growing 4.46% CAGR from healthcare adoption.

List of Top Cardiac Monitoring & Cardiac Rhythm Management Devices Companies

• SCHILLER
• Cardiac Science
• Medtronic
• St. Jude Medical
• LivaNova
• Boston Scientific
• Philips Healthcare
• BIOTRONIK
• GE Healthcare
• Mortara Instrument

Medtronic: Global leader with 20% market share, equal to 3.7 million device installations in 2024.

Boston Scientific: Ranked second with 14% share, representing 2.6 million installations worldwide.

Investment Analysis and Opportunities

Between 2022 and 2024, global investments in cardiac monitoring and rhythm management expanded by 25%, adding 4 million new devices to the installed base. North America attracted 40% of investments, equal to 1.6 million devices, focused on remote monitoring platforms. Europe invested in 1.2 million new devices, particularly implantable loop recorders. Asia-Pacific accounted for 1.1 million additional units, with government programs in China and India subsidizing adoption. Opportunities include wearable ECG patches, expected to grow from 1.2 million to 3 million by 2027, and AI-based diagnostics projected to cover 40% of devices by 2026.

New Product Development

From 2023–2025, over 20 new cardiac monitoring devices were launched globally. Medtronic introduced AI-powered implantable loop recorders, reducing false arrhythmia alerts by 25%. Boston Scientific launched compact cardiac output monitors, 30% smaller than previous models. Philips Healthcare introduced wearable ECG devices integrated with cloud platforms, monitoring 2 million patients in 2024. GE Healthcare developed remote patient monitoring systems tracking 500,000 patients in the USA. BIOTRONIK released Bluetooth-enabled event monitors covering 250,000 patients in Europe.

Five Recent Developments

• Medtronic launched AI-based loop recorders covering 500,000 patients globally in 2023.
• Boston Scientific expanded cardiac output monitor production by 400,000 units in 2024.
• Philips Healthcare introduced wearable ECG devices monitoring 2 million patients in 2024.
• GE Healthcare rolled out remote monitoring systems across 200 US hospitals in 2025.
• BIOTRONIK introduced Bluetooth-enabled event monitors adopted by 250,000 patients in 2024.

Report Coverage

The Cardiac Monitoring & Cardiac Rhythm Management Devices Market Market Research Report covers global demand of 18.5 million devices in 2024. By type, ECG devices represented 8 million, implantable loop recorders 2.5 million, cardiac output monitors 3.2 million, and event monitors 4.8 million. By application, hospitals used 12 million devices, while homecare and ambulatory accounted for 6.5 million. Regional coverage includes North America (6.8 million), Europe (5.2 million), Asia-Pacific (5.5 million), and Middle East & Africa (1 million). Competitive landscape features 10 major companies, with Medtronic and Boston Scientific leading at 34% combined share. The report documents over 20 product launches, 15 regional expansions, and 10 AI-driven developments between 2023–2025, providing insights into device volumes, patient coverage, technological adoption, and replacement demand.

Cardiac Monitoring & Cardiac Rhythm Management Devices Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 5258.3 Million in 2026
Market Size Value By	USD 35335.24 Million by 2035
Growth Rate	CAGR of 4.46% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : ECG Devices Implantable Loop Recorder Cardiac Output Monitoring Event Monitors By Application : Home and Ambulatory Care Hospitals
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample